APIs for research and impurities
Active Pharmaceutical Ingredients (APIs) are the substances in drugs responsible for their therapeutic effects. In this section, you will find a wide variety of APIs intended for research use. These compounds are essential for the development, testing, and validation of new pharmaceutical formulations. CymitQuimica offers high-quality APIs to support research in drug discovery and development.
Subcategories of "APIs for research and impurities"
- Alkaloids
- Aminoacids and derivatives
- Anthraquinones and derivatives
- Benzimidazole and Imidazole Derivatives
- Benzodiazepine Derivatives
- Carbohydrates and glycoconjugates
- Esters and Derivatives
- Fatty Acids and Lypidic Derivatives
- Flavonoids and Polyphenols
- Free Radicals and Oxidant/Reducing Agents
- Ketones and derivatives
- Natural and semi-synthetic antibiotics
- Nitriles and Cyano Derivatives
- Nitrosamines and Derivatives
- Nucleosides and Nucleotides
- Organic Phosphates and Phosphonates
- Organic Sulphonates and Sulphates
- Organometallics
- Others
- Peptides and Proteins
- Polymers and Derivatives
- Purines and Pyrimidine Derivatives
- Quinazoline and Quinoline Derivatives
- Quinones and Derivatives
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)
- Steroids and Derivatives
- Sulfonamides and Derivatives
- Terpenoids and Derivatives
- Thiazolidinediones and Thiopyrans
- β-Adrenergic Compounds
Show 22 more subcategories
Products of "APIs for research and impurities"
Sort by
1-[[2-[(2-Aminophenyl)amino]-5-methyl-3-thienyl]carbonyl]-4-methyl-piperazine
CAS:Please enquire for more information about 1-[[2-[(2-Aminophenyl)amino]-5-methyl-3-thienyl]carbonyl]-4-methyl-piperazine including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C17H22N4OSPurity:Min. 95%Molecular weight:330.45 g/molDibenzosuberone
CAS:Dibenzosuberone is a reactive, surfactant, and β-catenin inhibitor that has been shown to have anti-cancer activity against solid tumours. It is synthesized by the asymmetric synthesis of dibenzoyl-L-tartaric acid with sodium dodecylsulfate in the presence of light. The substrate film is used to increase the rate of reactivity. Dibenzosuberone inhibits the growth of cancer cells by inhibiting cyclic peptide synthesis and blocking light emission from these cells. Dibenzosuberone also has an effect on cell migration and proliferation through its interactions with β-catenin. Dibenzosuberone hydrolyzes in aqueous solution to form benzene, which can be removed by adding hydrochloric acid or hydrogen bonding with anhydrous sodium.Formula:C15H12OPurity:Min. 95%Color and Shape:Solidified MassMolecular weight:208.26 g/molIndacaterol Impurity 6 HCl
CAS:Formula:C13H19N·HClColor and Shape:White To Off-White SolidMolecular weight:189.30 36.46Vancomycin hydrochloride
CAS:Formula:C66H75Cl2N9O24·HClPurity:≤ 5.0%Color and Shape:White to tan powderMolecular weight:1485.73
![1-[[2-[(2-Aminophenyl)amino]-5-methyl-3-thienyl]carbonyl]-4-methyl-piperazine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIA183184.webp&w=3840&q=75)
